Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04910373
Other study ID # AL36
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 25, 2022
Est. completion date February 18, 2022

Study information

Verified date June 2022
Source Abbott Nutrition
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multi-center, randomized, double-blind, placebo-controlled food challenge to be conducted in infants or children with confirmed IgE-mediated cow's milk allergy (CMA), followed by a 7-day open feeding of the experimental formula.


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date February 18, 2022
Est. primary completion date February 18, 2022
Accepts healthy volunteers No
Gender All
Age group 3 Months to 12 Years
Eligibility Inclusion Criteria: - Participant has a physician diagnosis of IgE-mediated Cow's Milk Allergy (CMA) based on a clinical history of a reaction resulting in characteristic immediate hypersensitivity symptoms within 2 hours of oral exposure or immediate hypersensitivity symptoms according to physician's observation - Participant is willing to undergo confirmatory testing or must have had at least one of the following within 6 months of enrollment: 1. Documentation of milk-specific serum IgE >15 kIUA/L or > 5 kIUA/L if younger than 1 year. 2. Documented cow's milk skin prick test mean wheal >10mm 3. Physician-supervised oral food challenge that elicited immediate, objective, allergic symptoms. - Participant agrees to stop oral steroid use within 14 days and antihistamine use within 7 days of confirmation of diagnosis and food challenges. - Participant had followed a strict cow's milk protein-free diet prior to enrollment. - Parent(s) confirm their intention not to administer any products containing cow's milk protein during the study. - Participant's parent(s) has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study. Exclusion Criteria: - Participant is exclusively breastfed at the time of enrollment. - Participant is consuming an amino acid-based formula due to failure on an extensively hydrolyzed formula. - Significant chronic medical diseases including major chromosomal or congenital anomalies, gastrointestinal diseases or abnormalities other than CMA, immunodeficiencies, unstable asthma, asthma treated with biologics (omalizumab or other monoclonal antibody), FPIES, eosinophilic esophagitis, and severe uncontrolled eczema. - Previous severe anaphylactic reaction to cow's milk within the last two years. - An adverse medical history or current condition that is thought by the investigator to have potential for effects on tolerance or the hypoallergenicity test. - Participant has an allergy or intolerance to any ingredient in the study product, as reported by the parent. - Participant is routinely consuming baked milk products.

Study Design


Intervention

Other:
Experimental Extensively Hydrolyzed Formula
experimental powder formula
Placebo Extensively Hydrolyzed Formula
placebo powder formula

Locations

Country Name City State
United States Children's Healthcare of Atlanta Atlanta Georgia
United States Children's Hospital Colorado Aurora Colorado
United States UNC-Chapel Hill Chapel Hill North Carolina
United States The Children's Hospital of Philadelphia Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Abbott Nutrition

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Food Challenge Positive Reactions Percent of positive food challenge reactions to the experimental formula Food Challenge Day 1 to Food Challenge Day 2
Secondary Experimental Formula Intake Parent completed diaries of formula intake Home Feeding Day 1 to Day 7
Secondary Food Intake Parent completed diaries Home Feeding Day 1 to Day 7
Secondary Gastrointestinal Symptoms Parent completed diaries Home Feeding Day 1 to Day 7
Secondary Medication Use Parent completed diaries Home Feeding Day 1 to Day 7
Secondary Food Challenge Positive Reactions Percent of positive food challenge reactions to the experimental formula Home Feeding Day 1 to Day 7
See also
  Status Clinical Trial Phase
Completed NCT02738060 - The Effect of Baked Milk on Cow's Milk Allergy Phase 2
Recruiting NCT02149134 - Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy Phase 2
Recruiting NCT01891916 - Effect Of Lactobacillus GG on Atopic March N/A
Completed NCT01622426 - Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy N/A
Completed NCT01634490 - Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy N/A
Completed NCT02466035 - Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA) N/A
Completed NCT02379598 - Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy N/A
Completed NCT04330092 - Diagnosis of Cow's Milk Protein Allergy
Not yet recruiting NCT02081651 - Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy Phase 3
Completed NCT03462030 - Baked Milk Oral Immunotherapy for Cow's Milk Allergy Phase 2
Completed NCT02465905 - Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : "Petit Lait" Study N/A
Suspended NCT05731206 - Hypoallergenicity of a Hydrolyzed Protein Infant Formula N/A
Not yet recruiting NCT06456541 - Infant Formula in Infants and Children With Cow's Milk Allergy N/A
Recruiting NCT02062476 - Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy Phase 2
Completed NCT01589731 - Polymerized Beta-lactoglobulin Comparative Immunoreactivity N/A
Terminated NCT02405923 - Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy N/A
Recruiting NCT01968278 - Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients N/A
Withdrawn NCT01470768 - Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas N/A
Recruiting NCT05883384 - Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy
Completed NCT01901380 - Cow's Milk Allergy and Functional Gastrointestinal Disorders N/A